Using Ig-b b and growth hormone producing cells with liver-derived cells for controls, sensitivity of chromatin to DNase I was measured by real-time PCR at eleven targets in rat Ig-b b/growth hormone locus where four cell type-specific genes and two ubiquitously expressed genes are present in a compact 88-kb region. Chromatin situated at the promoter of actively-transcribed gene and placed at cell type-specific DNase I hypersensitive sites with enhancer activity was sensitive to DNase I. In the case of inactive gene, chromatin located in these regions was resistant to DNase I. Unexpectedly, however, chromatin placed in the transcribed intron was resistant to DNase I in two genes. DNase I sensitive chromatin was shown not to distribute locus-widely but rather to localize at the promoter and the enhancer of actively-transcribed genes in this locus.
Consequently, the chromatin structure of actively transcribed genes and their flanking regions has been considered distinct from that of inactive genes. In the compact 88-kb region of the rat Ig-b/growth hormone (GH) locus, six genes are present in the following order: skeletal muscle (SkM) sodium channel; Ig-b; GH; testicular cell adhesion molecule 1 (TCAM-1); BAF60b (a component of the chromatin remodeling factor); and p45/SUG (proteasome regulatory subunit/transcription factor) ( Fig. 1) . 6) Of the genes present at this locus, BAF60b and p45 are ubiquitously expressed, 7, 8) while SkM sodium channel, Ig-b, GH, and TCAM-1 are transcribed in specific cell types ontogenetically unrelated to each other. 6, 9, 10) The Ig-b gene encodes a membrane protein with a single transmembrane region, and is specifically expressed in B-lymphocytes. Ig-b protein is a component of the membrane immunoglobulin (mIg) receptor complex, 11) together with mIg and Ig-a. The TCAM-1 protein is a testisspecific membrane protein with a single transmembrane region. 6) Examination of chromatin sensitivity to DNase I has been reported for single genes and associated flanking regions, [1] [2] [3] 5) and on loci such as b-globin. 4) No such analyses have yet been performed on regions such as the rat Ig-b/GH locus, where several cell type-specific and ubiquitously-expressed genes are located in a compact region. We have established conditions for quantifying a tiny amount of DNA in this locus through real-time PCR (R-PCR) procedures. 12) Using Ig-b-producing plasmacytoma cells and GH-producing pituitary-derived cells, with liver-derived cells for controls, chromatin sensitivity to DNase I was examined at eleven targets located in promoter, enhancer, exon, intron and intergenic regions in the rat Ig-b/GH locus. Results were compared with reported acetylation and methylation patterns of nucleosome histones in this locus 12) together with reports on chromatin sensitivity to DNase I. [1] [2] [3] [4] [5] 
MATERIALS AND METHODS

Cells
Rat plasmacytoma-derived Y3 cells were obtained from the Japanese Cancer Research Resources Bank (Tokyo, Japan). Buffalo rat liver-derived BRL cells were obtained from RIKEN Cell Bank (Tsukuba, Japan). Rat pituitary-derived GC cells were obtained from M. Karin (University of California, San Diego, CA, U.S.A.). Propagation of cells was performed as previously described.
13)
Isolation of Nuclei, DNase I Digestion and Real-Time PCR (R-PCR) For DNase I general sensitivity analysis, nuclei were prepared and treated with DNase I (Takara Bio, Kyoto, Japan), and DNA was prepared as described.
13) R-PCR was performed using the Ex Taq R-PCR version (Takara Bio) and a commercial system (Smart Cycler System, Cepheid/Takara Bio) as described.
12) Sonicated DNA with average length of 600-700 bp was used for controls. DNA samples were quantified using picogreen (Molecular Probes, Eugene, OR, U.S.A.). Amplification and Tm profiles were determined by measuring fluorescence intensity of SYBR Green I nucleic acid gel stain (Cambrex, East Rutherford, U.S.A.). Typical conditions for R-PCR were as follows: mixture, 25 ml; polymerase, Ex Taq R-PCR Version (Takara Bio); 40 cycles, 94°C, 1 min; 65°C, 1 min; 72°C, 1.5 min. For quantification of DNA prepared from DNase-I treated nuclei, eleven targets (about 200 bp long) ( Fig. 1) were selected.
12)
RESULTS
Conditions for DNase I Treatment of Nuclei
We first examined conditions for DNase I treatment of nuclei in the analysis of chromatin sensitivity to DNase I using R-PCR methods.
12) The Y3, GC, and BRL DNA samples prepared from DNase I-treated nuclei were first analyzed using electrophoresis in an agarose gel ( Fig. 2A) . Content of the target sequence in these DNA samples was then determined by R-PCR assay (Figs. 2B, C). With DNA prepared from various amounts of DNase I-treated Y3 nuclei, nanogram equivalents of genomic DNA at targets 6 (GH exon 5/enhancer) and 7 (TCAM-1 intron 1) (Fig. 1) were quantified under R-PCR.
Using DNA fragments generally less than 0.6 kb long ( Fig.  2A , lane 4), content of target sequences was reduced to 7.8 ng at target 6 and 8.4 ng at target 7, although 20 ng of DNA was used for each estimation. As these targets are positioned in the DNase I-resistant region in Y3 cells (Fig. 1) , reduced content was caused by extensive DNase I digestion. Samples containing 20 ng equivalent of control Y3 DNA ( Fig. 2A : Y3, lane 2; GC, lane 6; BRL, lane 8) were therefore used for subsequent DNase I sensitivity analyses.
Verification of Targets for R-PCR Sensitivity of Y3, GC, and BRL chromatin to DNase I was examined at eleven targets (Fig. 1) . These eleven targets were present near the following sequences ( Fig. 1 ): five promoters (target 2, Ig-b; target 5, GH, target 8, TCAM-1; target 9, BAF60b; and target 11, p45); two Ig-b enhancers (targets 3 and 4); one GH exon/enhancer (target 6); two introns (target 7, TCAM-1; and target 10, BAF60b); and one sodium channel/Ig-b intergenic region. 12) As 20 ng DNA was used for R-PCR, presence of 20 ng equivalent of target indicates resistance of target chromatin, whereas content less than 20 ng indicates sensitivity to DNase I. Eight targets situated around the promoters (targets 2, 5, 8, 9, 11), Ig-b enhancers (targets 3, 4), and GH exon 5 (target 6) are positioned close to DNase I hypersensitive sites (DHS) (Figs. 1, 3) . 9, 13, 14) One possible explanation for reduced content of target sequences in DNase I-treated DNA may be disruption of the target sequence due to the presence of DHS in the target. For example, most DHS are cut by treatment of the nuclei with a lower concentration of DNase I. Less sensitive sites are then randomly digested with increasing amounts of DNase I. As the concentration of DNase I used for digestion of nuclei was at least 10-fold higher than that required for complete digestion of DHS, 9, 13) almost no DNA template would be left to be amplified if DHS were present within a target. Since targets close to the promoters of the GH, TCAM-1 and BAF60b genes are positioned at least 60 bp downstream from the transcriptional start site (Fig. 3) , DHS are unlikely to be present inside the target sequence. Conversely, targets close to promoters of the Ig-b 12) and p45 genes are located in regions corresponding to binding sites of the transcriptional initiation complex, and DHS may be mapped in these targets. Accordingly, DHS may be present in target 11 (p45 promoter), where target content was close to 0. In contrast, no DHS appear to be present in other targets, as more than 4 ng equivalent of DNA was estimated at these targets. Reduction of content by DNase I treatment therefore indicates enhancement of DNase I general sensitivity at these targets.
DNase I General Sensitivity in Ig-b b/GH Locus Chromatin Expression of six genes in the rat Ig-b/GH locus has been described 12) and shown at the bottom of Fig. 1 . It should be pointed out that Y3 cells possess TCAM-1 mRNA, reported to be specifically expressed in the testis. 6) Targets 9 (BAF60b promoter) and 11 (p45 promoter) were sensitive in all three cell lines. Targets 2 (Ig-b promoter), 3, 4 (Ig-b enhancer), and 8 (TCAM-1 promoter) were sensitive in Y3 cells and targets 1 (sodium channel/Ig-b intergenic region), 5 (GH promoter), 6 (GH exon/enhancer), and 8 (TCAM-1 promoter) were sensitive in GC cells. Targets 1, 5, and 6 were resistant in Y3 cells. Two targets (targets 7 and 10) present in the transcribed introns were also resistant in Y3 cells. Chromatin of target 10 (BAF60b intron 1) was resistant to DNase I in GC and BRL cells where the BAF60b gene is transcribed. 12) In GC cells, targets 2 (Ig-b promoter), 3, 4 (Ig-b enhancer), and 7 (TCAM-1 intron 1) were resistant. These results indicate that in the rat Ig-b/GH locus, chromatin close to promoters of transcribed genes is sensitive to DNase I digestion. Chromatin near Y3-specific DHS with enhancer activity was sensitive to DNase I in Y3 cells. However, targets in the transcribed intron of the TCAM-1 and BAF60b genes were resistant. In most cases, chromatin situated close to the promoter, exon, intron, or enhancer of an inactive gene or in the intergenic region was also resistant.
DISCUSSION
In the present study, chromatin sensitivity to DNase I in the rat Ig-b/GH locus was quantified using R-PCR methods. Chromatin in active promoters and cell type-specific DHS with enhancer activity displayed sensitivity to DNase I. Acetylation of H3 and H4 and methylation of H3-meK4 are enhanced in the above chromatin regions (Fig. 1) , 12) and thus the chromatin structures are likely to be in a relaxed form where the initiation complex and transcription factors can be easily accessed.
In contrast, chromatin at target 7 in TCAM-1 intron 1 and at target 10 in BAF60b intron 1 was resistant to DNase I even in cells expressing the genes. Chromatin located in the transcribed genes has previously been reported as sensitive to DNase I digestion. [1] [2] [3] [4] [5] The finding that chromatin in the transcribed intron is resistant to DNase I digestion is therefore of considerable interest. Since targets other than 7 and 10 were not analyzed as introns, further examination is required to determine whether intron chromatin in active genes is resistant to DNase I.
Intron chromatin in active TCAM-1 and BAF60b genes was resistant to DNase I, whereas histone modification differed markedly between the two introns: high in BAF60b and low in TCAM-1 (Fig. 1) . 12) Enhanced chromatin sensitivity to DNase I has already been reported as not always correlating with that of H3 and H4 acetylation. 15, 16) Intron 1 of the BAF60b gene in this study offers an example that enhancement of chromatin sensitivity to DNase I does not always precede enrichment of H3 and H4 acetylation. As details of the physical and chemical changes occurring in the process of enhanced chromatin sensitivity to DNase I are elucidated, the relationship between transcription factor binding, and structural and modification changes in chromatin at various regions of certain genes and the surroundings will be clarified. 224 Vol. 27, No. 2 
